SLC7A11 and urinary bladder carcinoma: High expression of SLC7A11 was significantly correlated with the poor OS and RFS in bladder carcinoma, breast cancer, kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, and pancreatic ductal adenocarcinoma (Table 1).